Skip to main content
. 2015 Jun 14;21(22):6884–6891. doi: 10.3748/wjg.v21.i22.6884

Figure 2.

Figure 2

miR-382 expression levels were associated with outcomes of esophageal squamous cell carcinoma patients. A: The esophageal squamous cell carcinoma (ESCC) patients with good outcome generally exhibited higher miR-382 expression than those with poor outcome (aP < 0.05, good outcome vs poor outcome); B: Stage I ESCC patients with good outcome exhibited higher levels of miR-382 than those with poor prognosis (aP < 0.05, good outcome vs poor outcome); C: Stage II ESCC with good outcome exhibited higher levels of miR-382 than those with poor outcome (aP < 0.05, good outcome vs poor outcome); D: Stage III ESCC with good outcome exhibited higher levels of miR-382 than those with poor outcome (aP < 0.05, good outcome vs poor outcome).